Indeterminate QuantiFERON-TB gold in-tube assay results in children: possible association with procedural specimen

Duc-Hieu P Bui1, Andrea T Cruz, Edward A Graviss

  • 1From the *University of Texas-Houston School of Public Health; †Department of Pediatrics, Baylor College of Medicine; and ‡Department of Pathology and Genomic Medicine, The Methodist Hospital Research Institute, Houston, TX.

Insights

Indeterminate QuantiFERON-TB Gold assays were common in children (31%). Inpatient status significantly increased the risk of indeterminate results, suggesting issues with specimen handling.

Area of Science:

  • Pediatric Infectious Diseases
  • Clinical Diagnostics

Background:

  • Tuberculosis (TB) infection screening in children is crucial.
  • QuantiFERON-TB Gold (QFT-GIT) is a common diagnostic tool.
  • Indeterminate results can hinder accurate diagnosis.

Purpose of the Study:

  • To identify factors associated with indeterminate QuantiFERON-TB Gold results in a pediatric population.
  • To investigate the impact of clinical factors on QFT-GIT assay validity.

Main Methods:

  • Retrospective analysis of QFT-GIT results in 182 children.
  • Statistical analysis to determine associations between indeterminate results and variables like age, gender, comorbidities, and inpatient status.

Main Results:

  • 31% (56/182) of QFT-GIT assays were indeterminate.
  • Indeterminate results were strongly associated with inpatient status (OR: 11.7, 95% CI: 3.9-34.9).
  • No significant association was found with age, gender, or medical comorbidities.

Conclusions:

  • Indeterminate QFT-GIT results are frequent in pediatric patients, particularly inpatients.
  • Specimen handling and procedural factors likely contribute to indeterminate results.
  • Enhanced training on specimen collection and handling may reduce indeterminate QFT-GIT assay rates in children.